Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.61

Prognostic Factors in Adult Patients with Solid Cancers and Bone Marrow Metastases  

Hung, Yu-Shin (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Chou, Wen-Chi (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Chen, Tai-Di (Department of Pathology, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Chen, Tse-Ching (Department of Pathology, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Wang, Po-Nan (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Chang, Hung (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Hsu, Hung-Chih (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Shen, Wen-Chi (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Cheng, Wei-Hong (Division of Hematology and Oncology, Departement of Internal Medicine, Taipei Medical University-Shung Ho hospital, Ministry of Health and Welfare)
Chen, Jen-Shi (Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, and School of Medicine, Chang Gung University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 61-67 More about this Journal
Abstract
Background: Solid cancers with bone marrow metastases are rare but lethal. This study aimed to identify clinical factors predictive of survival in adult patients with solid cancers and bone marrow metastases. Methods: A total of 83 patients were enrolled consecutively between January 1, 2000 and December 31, 2012. Bone marrow metastases were confirmed by biopsies. Patient clinical features and laboratory data were analyzed for associations. Results: The median age of the patients was 54 years (range, 23-88 years), and 58% were male. The 3 most common primary tumor locations were the stomach (32 patients, 39%), prostate (16 patients, 19%), and lungs (12 patients, 15%). The median overall survival was 49 days (range, 3-1423 days). Patients with Eastern Cooperative Oncology Group performance status 1, cancers of prostate origin, platelet counts over 50,000/ml, and undergoing antitumor therapies had a significantly better prognosis in the multivariate analysis. The median survival times were 173 and 33 days for patients with 2-3 more favorable parameters (n=24) and those with 0-1 (n=69), respectively (hazard ratio 0.30; 95% CI 0.17-0.52, p<0.001). Conclusions: Solid cancers with bone marrow metastases are dismal and incurable diseases. Understanding prognostic factors to these diseases helps medical personnel to provide appropriate treatments and better inform patients about outcomes. Antitumor therapies may improve outcomes in selected patient cohorts.
Keywords
Solid cancer; bone marrow metastasis; prognosis; antitumor therapy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mehdi SR, Bhatt ML (2011). Metastasis of Solid Tumors in Bone Marrow: A Study from Northern India. Indian J Hematol Blood Transfus, 27, 93-5.   DOI   ScienceOn
2 Kim HS, Yi SY, Jun HJ, et al (2007). Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology, 73, 192-7.   DOI   ScienceOn
3 Kwon JY, Yun J, Kim HJ, et al (2011). Clinical outcome of gastric cancer patients with bone marrow metastases. Cancer Res Treat, 43, 244-9.   DOI   ScienceOn
4 McFarland W, Dameshek W (1958). Biopsy of bone marrow with the Vim-Silverman needle. JAMA, 166, 1464-6.   DOI
5 Burkhardt R, Frisch B, Bartl R, et al (1981). Detection of haematologic and nonhaematologic cancer by bone biopsy. Cancer Detect Prev, 4, 619-27.
6 Wong KF, Chan JK, Ma SK (1993). Solid tumour with initial presentation in the bone marrow-a clinicopathologic study of 25 adult cases. Hematol Oncol, 11, 35-42.   DOI   ScienceOn
7 Xiao L, Luxi S, Ying T, et al (2009). Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples. J Cancer Res Clin Oncol, 135, 687-93.   DOI
8 Al-Sarraf M, LeBlanc M, Giri PG, et al (1988). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol, 16, 1310-7.
9 Ceci G, Franciosi V, Passalacqua R, et al (1988). The value of bone marrow biopsy in breast cancer at the time of first relapse: a prospective study. Cancer, 61, 1041-5.   DOI
10 Diel IJ, Kaufmann M, Goemer R, et al (1992). Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastases. J Clin Oncol, 10, 1534-9.
11 Dunn P, Shih LY, Liaw SJ, Sun CF (1993). Bone marrow necrosis in 38 adult cancer patients. J Formos Med Assoc, 92, 1107-10.
12 Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47.   DOI   ScienceOn
13 Forrest DL, Mack BJ, Nevill TJ, et al (2000). Bone marrow necrosis in adult acute leukemia and non-Hodgkin's lymphoma. Leuk Lymphoma, 38, 627-32.   DOI   ScienceOn
14 Hansen HH, Muggia FM, Selawry OS (1971). Bone marrow examination in 100 consecutive patients with bronchogenic carcinoma. Lancet, 2, 443-5.
15 Ozkalemkas F, Ali R, Ozkocaman V, et al (2005). The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer, 5, 144.   DOI
16 Papac RJ (1994). Bone marrow metastases: a review. Cancer, 74, 2403-13.   DOI
17 Paydas S, Ergin M, Baslamisli F, et al (2002). Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am J Hematol, 70, 300-5.   DOI   ScienceOn
18 Shah NT, Tuttle SE, Strobe1 SL, Gandhi L (1985). Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material. J Surg Oncol, 29, 265-8.   DOI   ScienceOn
19 Ringenberg QS, Doll DC, Yarbro JW, Perry MC (1986). Tumors of unknown origin in the bone marrow. Arch Intern Med, 146, 2027-8.   DOI   ScienceOn
20 Sar R, Aydogdu I, Ozen S, Sevinc A, Buyukberber S (2001). Metastatic bone marrow tumours: a report of six cases and review of the literature. Haematologia (Budap), 31, 215-23.   DOI   ScienceOn
21 Taiwan Health Registry Annual Report (2009). Bureau of Health Promotion, Department of Health, Executive Yuan, Republic of China. Available from: http://www2.cmu.edu.tw/-biostat/ online/DOH1000602.pdf (Last accessed May 20 2013)
22 Trillet-Lenoir VN, Arpin D, Brune J (1994). Bone marrow metastases detection in small cell lung cancer. A review. Anticancer Res, 14, 2795-7.
23 Tritz DB, Doll DC, Ringenberg QS, et al (1989). Bone marrow involvement in small cell lung cancer. Cancer, 63, 763-6.   DOI
24 Wang JM, Shin LY, Lai GM, NG KT (1987). Bone marrow metastases from solid Tumors: clinical analysis of 96 cases. Chang Gung Med J, 10, 283-93.